BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37460268)

  • 1. Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort.
    Van Deutekom C; Geelhoed B; Van Munster BC; Bakker SJL; Gansevoort RT; Van Gelder IC; Rienstra M
    Open Heart; 2023 Jul; 10(2):. PubMed ID: 37460268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study.
    Zwartkruis VW; Geelhoed B; Suthahar N; Bakker SJL; Gansevoort RT; van Gelder IC; de Boer RA; Rienstra M
    Open Heart; 2021 Dec; 8(2):. PubMed ID: 34969833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of renal dysfunction with incident atrial fibrillation and cardiovascular morbidity and mortality: The PREVEND study.
    Marcos EG; Geelhoed B; Van Der Harst P; Bakker SJL; Gansevoort RT; Hillege HL; Van Gelder IC; Rienstra M
    Europace; 2017 Dec; 19(12):1930-1936. PubMed ID: 28108549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
    Vermond RA; Geelhoed B; Verweij N; Tieleman RG; Van der Harst P; Hillege HL; Van Gilst WH; Van Gelder IC; Rienstra M
    J Am Coll Cardiol; 2015 Sep; 66(9):1000-7. PubMed ID: 26314526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study.
    Vanbeselaere V; Truyers C; Elli S; Buntinx F; De Witte H; Degryse J; Henrard S; Vaes B
    BMC Cardiovasc Disord; 2016 Mar; 16():61. PubMed ID: 27021333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations.
    Rienstra M; Geelhoed B; Yin X; Siland JE; Vermond RA; Mulder BA; Van Der Harst P; Hillege HL; Benjamin EJ; Van Gelder IC
    PLoS One; 2016; 11(11):e0165828. PubMed ID: 27832125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and clinical outcomes in atrial fibrillation patients classified using cluster analysis: the Fushimi AF Registry.
    Ogawa H; An Y; Nishi H; Fukuda S; Ishigami K; Ikeda S; Doi K; Ide Y; Hamatani Y; Fujino A; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Tsukahara T; Lip GYH; Akao M;
    Europace; 2021 Sep; 23(9):1369-1379. PubMed ID: 33930126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.
    Chao TF; Lip GYH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
    Eur Heart J; 2019 May; 40(19):1504-1514. PubMed ID: 30605505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing (FIT) Project.
    Qureshi WT; Alirhayim Z; Blaha MJ; Juraschek SP; Keteyian SJ; Brawner CA; Al-Mallah MH
    Circulation; 2015 May; 131(21):1827-34. PubMed ID: 25904645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere length and incident atrial fibrillation - data of the PREVEND cohort.
    Siland JE; Geelhoed B; van Gelder IC; van der Harst P; Rienstra M
    PLoS One; 2017; 12(2):e0171545. PubMed ID: 28158257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study).
    Kim EJ; Yin X; Fontes JD; Magnani JW; Lubitz SA; McManus DD; Seshadri S; Vasan RS; Ellinor PT; Larson MG; Benjamin EJ; Rienstra M
    Am Heart J; 2016 Jul; 177():138-44. PubMed ID: 27297859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Chamberlain AM; Alonso A; Gersh BJ; Manemann SM; Killian JM; Weston SA; Byrne M; Roger VL
    Am Heart J; 2017 Mar; 185():74-84. PubMed ID: 28267478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimorbidity in patients with atrial fibrillation.
    Lobeek M; Middeldorp ME; Van Gelder IC; Rienstra M
    Open Heart; 2024 Mar; 11(1):. PubMed ID: 38508658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular disease.
    Sison SDM; Lin KJ; Najafzadeh M; Ko D; Patorno E; Bessette LG; Zakoul H; Kim DH
    J Am Geriatr Soc; 2023 Oct; 71(10):3179-3188. PubMed ID: 37354026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Bipolar Disorder or Schizophrenia and Oral Anticoagulation Use in Danish Adults With Incident or Prevalent Atrial Fibrillation.
    Fenger-Grøn M; Vestergaard CH; Ribe AR; Johnsen SP; Frost L; Sandbæk A; Davydow DS
    JAMA Netw Open; 2021 May; 4(5):e2110096. PubMed ID: 33999163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation. An analysis of 425,600 Chinese individuals without prior stroke.
    Guo Y; Wang H; Tian Y; Wang Y; Lip GY
    Thromb Haemost; 2016 Jan; 115(1):184-92. PubMed ID: 26322338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study.
    Hobbelt AH; Siland JE; Geelhoed B; Van Der Harst P; Hillege HL; Van Gelder IC; Rienstra M
    Europace; 2017 Feb; 19(2):226-232. PubMed ID: 28175276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and associating factors of atrial fibrillation in patients with hypertension: a nation-wide study.
    Krittayaphong R; Rangsin R; Thinkhamrop B; Hurst C; Rattanamongkolgul S; Sripaiboonkij N; Yindeengam A
    BMC Cardiovasc Disord; 2016 Mar; 16():57. PubMed ID: 27004563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Atrial Fibrillation Without Cardiovascular Comorbidities and Stroke Risk: From the REGARDS Study.
    Singleton MJ; Imtiaz-Ahmad M; Kamel H; O'Neal WT; Judd SE; Howard VJ; Howard G; Soliman EZ; Bhave PD
    J Am Heart Assoc; 2020 Jun; 9(12):e016380. PubMed ID: 32495723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.
    Bansal N; Fan D; Hsu CY; Ordonez JD; Marcus GM; Go AS
    Circulation; 2013 Feb; 127(5):569-74. PubMed ID: 23275377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.